The Health Minster of Panama, Luis Sucre, said on 7 February 2021 that Panama is seeking to acquire over eight million COVID-19 vaccine doses to inoculate about 80% of the country's residents, Reuters news agency reported on Monday.
According to Sucre, Panama has requested about one million doses from the COVID-19 vaccine portfolio under the COVAX facility coordinated by the World Health Organisation to support lower-income countries.
It will acquire a further three million doses from US pharmaceutical firm Pfizer Inc and the same amount from Russia, which has developed the Sputnik V COVID-19 vaccine.
Sucre added that Panama also aims to acquire 1.1 million doses manufactured by AstraZeneca PLC and 300,000 shots produced by Johnson & Johnson.
Reportedly, Panama has a population of about 4.2 million people but most COVID-19 vaccines require two shots spaced several weeks apart.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government